AVRO INDIA LIMITED — Important, 28-03-2025: Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

Avro India Limited has received approvals from the National Stock Exchange and BSE for trading 25,75,320 equity shares issued at a premium of ₹175.50 on a preferential basis, effective March 28, 2025. This listing may enhance liquidity and potential market interest, reinforcing investor confidence. With these new shares being part of a strategic move to attract non-promoters, the implications could lead to a strengthening of the company’s capital structure. Investors might view this positively, as it presents an opportunity for increased shareholder value and engagement, while it also introduces potential dilution risk.